SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
25-Mar-24 4:01 PM View: | Eliya Yehuda Director | Raphael Pharmaceutical Inc. (NONE) | 25-Nov-23 | Grant | 150,000 | $0.40 | $60,000.00 | 74% 202.0K to 352.0K | |
25-Mar-24 4:01 PM View: | Louria Hayon Igal Chief Technology Officer Director | Raphael Pharmaceutical Inc. (NONE) | 29-Aug-23 | Exercise (in-the money or at-the-money) | 999,000 | $0.01 | $9,990.00 | 100% 0 to 999.0K | |
13-Mar-23 4:01 PM View: | Ofir Guy Chief Financial Officer Director | Raphael Pharmaceutical Inc. (NONE) | 26-Jul-22 | Grant | 1,000,000 | -- | -- | 375% 266.46K to 1.27M | |
13-Mar-23 4:02 PM View: | Press Joseph Director | Raphael Pharmaceutical Inc. (NONE) | 26-Jul-22 | Grant | 280,000 | -- | -- | 100% 0 to 280.0K | |
16-Feb-10 4:26 PM View: | Ofir Guy President Director 10% Owner | Raphael Pharmaceutical Inc. (NONE) | 17-Dec-09 | Private Purchase | 990,000 | $0.05 | $54,450.00 | 4% 26.02M to 27.02M | |
16-Feb-10 4:26 PM View: | Ofir Guy President Director 10% Owner | Raphael Pharmaceutical Inc. (NONE) | 26-Nov-09 | Market Purchase | 286,000 | $0.06 | $17,160.00 | 1% 25.74M to 26.02M | (42%) |
16-Feb-10 4:26 PM View: | Ofir Guy President Director 10% Owner | Raphael Pharmaceutical Inc. (NONE) | 28-Oct-09 | Acquisition (other) | 425,000 | -- | -- | 2% 25.31M to 25.74M | |
22-Sep-09 2:41 PM View: | Ofir Guy President Director 10% Owner | Raphael Pharmaceutical Inc. (NONE) | 22-Sep-09 | Purchase | 1,000,000 | $0.15 | $150,000.00 | 4% 24.31M to 25.31M | |
22-Sep-09 2:41 PM View: | Ofir Guy President Director 10% Owner | Raphael Pharmaceutical Inc. (NONE) | 03-Sep-09 | Purchase | 404,153 | $0.09 | $38,394.50 | 2% 23.91M to 24.31M | |
04-Dec-08 10:59 AM View: | Ofir Guy President Director 10% Owner | Raphael Pharmaceutical Inc. (NONE) | 02-Dec-08 | Market Purchase | 200,000 | $0.06 | $12,500.00 | < 1% 23.71M to 23.91M | (65%) |
25-Nov-08 5:41 PM View: | Ofir Guy President Director 10% Owner | Raphael Pharmaceutical Inc. (NONE) | 24-Nov-08 | Market Purchase | 15,000 | $0.08 | $1,200.00 | < 1% 23.64M to 23.66M | (73%) |
25-Nov-08 5:41 PM View: | Ofir Guy President Director 10% Owner | Raphael Pharmaceutical Inc. (NONE) | 24-Nov-08 | Market Purchase | 50,000 | $0.08 | $4,050.00 | < 1% 23.66M to 23.71M | (73%) |
25-Nov-08 5:41 PM View: | Ofir Guy President Director 10% Owner | Raphael Pharmaceutical Inc. (NONE) | 12-Nov-08 | Purchase | 50,000 | $0.10 | $5,000.00 | < 1% 23.59M to 23.64M | (20%) |
25-Nov-08 5:41 PM View: | Ofir Guy President Director 10% Owner | Raphael Pharmaceutical Inc. (NONE) | 04-Nov-08 | Purchase | 55,000 | $0.15 | $8,350.00 | < 1% 23.54M to 23.59M | (47%) |
03-Oct-08 10:26 AM View: | Ofir Guy President Director 10% Owner | Raphael Pharmaceutical Inc. (NONE) | 30-Sep-08 | Market Purchase | 43,500 | $0.15 | $6,475.00 | < 1% 23.52M to 23.57M | (85%) |
29-Sep-08 2:17 PM View: | Ofir Guy President Director 10% Owner | Raphael Pharmaceutical Inc. (NONE) | 29-Sep-08 | Purchase | -- | -- | -- | 0% 2.02M | |
29-Sep-08 2:17 PM View: | Ofir Guy President Director 10% Owner | Raphael Pharmaceutical Inc. (NONE) | 29-Sep-08 | Market Purchase | 5,000 | $0.15 | $750.00 | < 1% 2.02M to 2.02M | (85%) |
29-Sep-08 2:17 PM View: | Ofir Guy President Director 10% Owner | Raphael Pharmaceutical Inc. (NONE) | 26-Sep-08 | Market Purchase | 20,000 | $0.15 | $3,000.00 | < 1% 2.0M to 2.02M | (85%) |